secwatch.observer — SEC 8-K summary
======================================

Issuer:     Runway Growth Finance Corp. (RWAY)
CIK:        0001653384
Form:       8-K
Filed at:   2023-07-31T23:59:59+00:00
Accession:  0001104659-23-085894
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO R. David Spreng takes temporary medical leave; acting CEO Greifeld appointed
--------------------------------------------------------------------------------

- R. David Spreng, Chairman, President & CEO, is taking temporary medical leave effective July 31, 2023.
- Greg Greifeld appointed Acting CEO; Thomas Raterman appointed Acting President, both effective immediately.
- Julie Persily appointed Acting Chairperson of the Board and Lead Independent Director.
- Succession plan approved by Compensation Committee on April 6, 2023; day-to-day operations to be uninterrupted.
- Runway Growth will provide operational update on Q2 earnings call scheduled for August 8, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1653384/000110465923085894/0001104659-23-085894-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1653384/000110465923085894/tm2322464d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-085894

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer